Blood gas analysers and monitors

Immediate bedside results increase sales

In 2006 blood gas analysers and monitors earned manufacturers revenues of around US$360.5 million, and revenues could reach US$470 million in 2013, according to a new market report from Frost & Sullivan (F&S).

Siemens Medical Solutions RapidPoint® 400 Series
Siemens Medical Solutions RapidPoint® 400 Series

‘Laboratory tests that used to take around 30 minutes for the result to be obtained are now a thing of the past; currently manufactured point of care devices yield immediate answers,’ the report’s author, research analyst C R Hema Varshika, explained. That instant bedside capability, along with a rising patient population is, she believes, the cause of a notable sales boost. 


The main challenges for manufacturers include each country having its own purchasing system, which will only change when countries adopt uniform laws. The author attributes other problems to the high levels of brand consciousness among hospitals and ‘intense competition from local participants’. This, Ms Farshika suggests, can be overcome through innovative products and effective marketing strategies. ‘Proactive marketing of technologically advanced and user-friendly products will lead to a rise in market share,’ she then predicts.


F&S points out that this analysis - ‘The European Blood Gas Analysers and Monitors Market’ (M00B – 56) - is part of its Patient Monitoring Subscription, which includes research on: Remote Patient Monitoring and the Strategic Analysis of the European Neurological Monitoring Market.

For a virtual brochure, e-mail Radhika Menon Theodore - Corporate Communications at rmtheodore@frost.com, giving your name, company name, title, phone number, e-address, city, state, and country.

(http://www.patientmonitoring.frost.com)

08.03.2007

More on the subject:

Related articles

Photo

News • Effects of smartwatch alerts

Heart rate monitoring: wearable devices can drive anxiety, possibly affect health

For patients with atrial fibrillation, using a wearable device can lead to higher anxiety about symptoms and treatment, doctor visits, and use of informal healthcare resources, a new study finds.

Photo

Opinion article • Wearable medical devices

Sweat analysis reveals a wealth of health information

Diagnosis and monitoring medical conditions, including cancer, diabetes, heart disease, and infections: In this opinion article, Alix Joseph (Linxens) explores the potential of sweat analysis.

Photo

News • Circulating tumor extracellular vesicles

Metastatic prostate cancer: better monitoring with new liquid biopsy method

A new study shows that extracellular vesicles shed by prostate cancer cells contain tumor-derived material that can be used as biomarkers of therapy response and resistance in metastatic disease.

Related products

Subscribe to Newsletter